Vikas Dharnidharka, M.D., M.P.H.

Director, Division of Pediatric Nephrology, Hypertension and Pheresis
Professor of Pediatrics, Nephrology
Patient Oriented Research UnitNephrology

phone: (314) 286-1574

Clinical Interests

I provide highly specialized care to children and young adults with all types of kidney disease, with a specific focus on end-stage renal disease and kidney transplantation. I am frequently consulted by colleagues throughout the world to advise with difficult complications of solid organ transplantation. I run a half-day outpatient pediatric nephrology clinic per week, mostly devoted to kidney transplant patients, but I also see patients sent for consultation by other pediatricians as well as patients previously under my care. When in charge of the pediatric nephrology inpatient service, I provide care to children with kidney problems admitted under my charge, consultative service to the other pediatric patients for kidney-related problems, and to the outpatient chronic hemodialysis and peritoneal dialysis patients at Shands Hospital. I perform kidney biopsies and acute hemodialysis or peritoneal dialysis in patients needing these specialized procedures. I also perform plasmapheresis and cellular apheresis for children with renal or non-renal diseases at St. Louis Children’s Hospital. As part of clinical care quality assurance and continuous quality improvement, I review on a very regular basis the quality measures related to procedures (biopsy complication rates), chronic dialysis (vascular access rates, anemia management, bone mineral management, immunization rates) and transplantation (patient and organ graft survival, immunization rates). My research interests are focused on end stage renal disease. I investigate the epidemiology of over-immunosuppression complications in transplantation using large national database linkages. I investigate biomarkers of acute and chronic rejection in translational studies (NIH grant R01DK102981, PI: Dharnidharka). I am investigating the microbial genomic patterns in stored paraffin tissue blocks of post-transplant lymphoproliferative disorder (Children’s Discovery Institute grant MC-II-2014-394, PI: Dharnidharka) . I am part of a consortium performing a randomized trial to improve adherence in teenagers with a kidney transplant and in consortia that study acute kidney injury (NIH grant R01 DK092977, PI: Foster). I am a site investigator in several industry studies of chronic kidney disease medications in children.


  • M.D., Topiwala National Medical College, Bombay University1991
  • MPH, University of Florida College of Public Health2007
  • MBBS, Topiwala National Medical College, (Affiliated with Bombay University)1988


  • Internship, Topiwala National Medical College & Bombay University1987 - 1988
  • Diploma in Child Health (DCH), College of Physicians and Surgeons1988 - 1990
  • Pediatrics Residency, BYL Nair Hospital & Topiwala National Medical College1988 - 1991
  • Pediatrics Residency, Children's Hospital of Michigan & Wayne State University1993 - 1995
  • Pediatric Nephrology Fellowship, Children's Hospital and Harvard Medical School1995 - 1998
  • Advanced Post Graduate Program in Clinical Investigation (APPCI), University of Florida2005 - 2007

Licensure and Board Certification

  • Maharashtra State Medical Council, India1988
  • Diplomate, National Board of Examinations in Pediatrics, New Delhi, India1991
  • State of Michigan1993
  • NALS/Neonatal Advanced Life Support, American Heart Association1993
  • PALS/Pediatric Advanced Life Support , American Heart Association1993
  • Diplomate; American Board of Pediatric, Chapel Hill, NC1995
  • Board of Registration, Commonwealth of Massachusetts1995
  • Diplomate, Sub-Board in Pediatric Nephrology, American Board of Pediatrics, Chapel Hill, NC1999
  • FL, Board of Medicine, State of Florida 1999
  • General Pediatrics, American Board of Pediatrics, Chapel Hill, NC2003
  • Graduate Record Examination, Educational Testing Service 2005
  • Recertification, Pediatric Nephrology2006
  • Missouri Board of Registration for the Healing Arts 2012
  • State of Illinois2014
  • Recertification, Pediatric Nephrology2016


  • Best Doctors in America 2015-2016
  • National Talent Search Scholarship, National Council of Educational Research and Training, Government of India, New Delhi, Inda1980 - 1990
  • Jane Patrao Award (Bronze Medal), 3rd among college class of 100 in entrance examination to T N Medical College, Bombay, India1982
  • H A Maniar Prize (Gold Metal), First among college class of 1991 in Forensic medicine at the 2nd MBBS University examination, Bombay, India1985
  • Bombay University Merit Scholarship, Bombay, India1988 - 1991
  • Best Resident Award, BYL Nair Hospital, Bombay, India1990 - 1991
  • Dr. V B Raju Young Investigators Award, Indian Academy of Pediatrics1992
  • 1st Prize for Best Abstract, Resident Abstract Competition, Michigan Association of Physicians from India1993
  • Hargobind Medical Fellowship Award, Hargobind Foundation, Bombay, India1993
  • Rameshwar Das Birla Fellowship Award, Bombay Hospital Institute Medical Trust, Bombay, India1993
  • The Resident Award for Outstanding Scientific Research, National Convention of the American Association of Physicians from India1994
  • Sheldon Brenner Award for Best Resident Research , Children's Hospital of Michigan1995
  • Physician Recognition Award, American Medical Association1996
  • ASTP Young Investigator Award, American Society of Transplant Physicians1998
  • AST Young Investigator Award, American Society of Transplantation1999
  • Young Investigator Award, International Pediatric Transplant Association2000
  • AAI Junior Faculty Award, American Association of Immunologists2001
  • Physician Recognition Award, American Medical Association2001
  • Society for Pediatric Research, Election to Membership2002
  • ASN Young Investigator Award, American Society of Nephrology2003
  • Physician Recognition Award, American Medical Association2004
  • Junior Faculty Travel Award, 32nd Pediatric Nephrology Seminar Series2005
  • Vice-President's APPCI Fellowship Award, University of Florida2005
  • AST-Wyeth Achievement Award for Assistant Professors in Clinical Science, American Society of Transplantation2006
  • Travel Grant, American Society of Nephrology2006
  • Vocational Service Award, Rotary Club of Bombay Peninsula2006
  • Young Investigator Award, North American Pediatric Transplant Cooperative Study2006
  • Expert Faculty Resource Service, American Society of Transplantation2006 - 2007
  • Young Investigator Award, 5th Immunology of Diabetes International Congress2007
  • Best Doctors in America2007 - 2008
  • Faculty Enhancement Opportunity Award, University of Florida2008
  • Certificate of Recognition, Outstanding Achievement in Pediatric Medical Student Education2008 - 2009
  • Best Doctors in America2009 - 2010
  • Inducted into Delta Omega, Honorary Alumni Society in Public Health, University of Florida's College of Public Health and Health Professions' Beta Epsilon Chapter2010
  • Best Doctors in America2011 - 2012
  • AST Investigator Achievement Award Clinical Science, American Society of Transplantation2012
  • Best Doctors in America2013 - 2014
  • Best Doctors in America2015 - 2016
  • Best Doctors in America2016 - 2017

Recent Publications view all (156)

Publication Co-Authors

  1. Lovric S, Goncalves S, Gee HY, Oskouian B, Srinivas H, Choi WI, Shril S, Ashraf S, Tan W, Rao J, Airik M, Schapiro D, Braun DA, Sadowski CE, Widmeier E, Jobst-Schwan T, Schmidt JM, Girik V, Capitani G, Suh JH, Lachaussée N, Arrondel C, Patat J, Gribouval O, Furlano M, Boyer O, Schmitt A, Vuiblet V, Hashmi S, Wilcken R, Bernier FP, Innes AM, Parboosingh JS, Lamont RE, Midgley JP, Wright N, Majewski J, Zenker M, Schaefer F, Kuss N, Greil J, Giese T, Schwarz K, Catheline V, Schanze D, Franke I, Sznajer Y, Truant AS, Adams B, Désir J, Biemann R, Pei Y, Ars E, Lloberas N, Madrid A, Dharnidharka VR, Connolly AM, Willing MC, Cooper MA, Lifton RP, Simons M, Riezman H, Antignac C, Saba JD, Hildebrandt F. Mutations in sphingosine-1-phosphase lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest. 2017. PMID:28165339  
  2. Maliakkal JG, Brennan DC, Goss C, Horwedel TA, Chen H, Fong DK, Agarwal N, Zheng J, Schechtman KB, Dharnidharka VR. Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation. Transpl Int. 2017;30(2):153-161. PMID:27862417  
  3. Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, AWARE Investigators.. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. N Engl J Med. 2017;376(1):11-20. PMID:27959707  
  4. Axelrod D, Schnitzler MA, Xiao H, Naik AS, Segev DL, Dharnidharka VR, Brennan DC, Lentine KL. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis. Am J Transplant. 2016. PMID:27565133  
  5. Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL. Differential Risks for Adverse Outcomes 3-Years after Kidney Transplantation Based on Initial Immunosuppression Regimen: A National Study. Transpl Int. 2016. PMID:27564782  
  6. Kulsum-Mecci N, Goss C, Kozel BA, Garbutt JM, Schechtman KB, Dharnidharka VR. Effects of Obesity and Hypertension on Pulse Wave Velocity in Children. J Clin Hypertens (Greenwich). 2016. PMID:27511880  
  7. Dharnidharka VR, Naik AS, Axelrod D, Schnitzler MA, Xiao H, Brennan DC, Segev DL, Randall H, Chen J, Kasiske B, Lentine KL. Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation. 2016. PMID:27490413  
  8. Dharnidharka VR. Peripheral blood Epstein-Barr viral nucleic acid surveillance as a marker for post-transplant cancer risk. Am J Transplant. 2016. doi:10.1111/ajt.13982  PMID:27458691  
  9. Alhamad T, Brennan DC, Brifkani Z, Xiao H, Schnitzler MA, Dharnidharka VR, Axelrod D, Segev DL, Lentine KL. Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation. Transplantation. 2016. doi:10.1097/TP.0000000000001113  PMID:26950718  
  10. Axelrod D, Naik AS, Schnitzler MA, Segev DL, Dharnidharka VR, Brennan DC, Bae S, Chen J, Massie A, Lentine KL. National variation in use of Immunosuppression for kidney transplantation: A call for evidence-based regimen selection. Am J Transplant. 2016. doi:10.1111/ajt.13758  PMID:26901466  
  11. Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016;2:15088. doi:10.1038/nrdp.2015.88  PMID:27189056  
  12. Lentine KL, Naik AS, Schnitzler M, Axelrod D, Chen J, Brennan DC, Segev DL, Kasiske BL, Randall H, Dharnidharka VR. Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data. Transplant Proc. 2016;48(1):55-8. doi:10.1016/j.transproceed.2015.12.024  PMID:26915843  
  13. Danziger-Isakov L, Frazier TW, Worley S, Williams N, Shellmer D, Dharnidharka VR, Gupta NA, Ikle D, Sweet SC, CTOTC-05 Consortium. Perceived barriers to medication adherence in pediatric and adolescent solid organ transplantation. Pediatr Transplant. 2015. doi:10.1111/petr.12648  PMID:26670870  
  14. Axelrod D, Segev DL, Xiao H, Schnitzler MA, Brennan DC, Dharnidharka VR, Orandi BJ, Naik AS, Randall H, Tuttle-Newhall JE, Lentine KL. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients. Am J Transplant. 2015. doi:10.1111/ajt.13616  PMID:26603690  
  15. Foster BJ, Dahhou M, Zhang X, Dharnidharka VR, Conway J, Ng VL. High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood. Transplantation. 2015. doi:10.1097/TP.0000000000001009  PMID:26588009  
  16. Naik AS, Dharnidharka VR, Schnitzler MA, Brennan DC, Segev DL, Axelrod D, Xiao H, Kucirka L, Chen J, Lentine KL. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int. 2015. doi:10.1111/tri.12711  PMID:26563524  
  17. Ashoor IF, Dharnidharka VR. Sexually transmitted infection screening and reproductive health counseling in adolescent renal transplant recipients: Perceptions and practice patterns. A study from the Midwest Pediatric Nephrology Consortium. Pediatr Transplant. 2015. doi:10.1111/petr.12579  PMID:26260626  
  18. Hesemann LE, Subramanian V, Mohanakumar T, Dharnidharka VR. De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children. Pediatr Transplant. 2015;19(5):499-503. doi:10.1111/petr.12531  PMCID:PMC4485575  PMID:26058970  
  19. Dharnidharka VR, Lamb KE, Zheng J, Schechtman KB, Meier-Kriesche HU. Lack of significant improvements in long-term allograft survival in pediatric solid organ transplantation: A US national registry analysis. Pediatr Transplant. 2015;19(5):477-83. doi:10.1111/petr.12465  PMID:25832769  
  20. Dharnidharka VR, Lamb KE, Zheng J, Schechtman KB, Meier-Kriesche HU. Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: A US national registry analysis. Pediatr Transplant. 2015;19(5):471-6. doi:10.1111/petr.12464  PMID:25832588  
  21. Foster BJ, Dahhou M, Zhang X, Dharnidharka V, Ng V, Conway J. High Risk of Graft Failure in Emerging Adult Heart Transplant Recipients. Am J Transplant. 2015. doi:10.1111/ajt.13386  PMID:26189336  
  22. Dharnidharka VR, Seifert ME. Kidney transplant results in children: progress made, but blacks lag behind. Kidney Int. 2015;87(3):492-4. PMCID:PMC4378232  PMID:25723630  
  23. Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, Andringa J, Goldstein SL, Prospective Pediatric AKI Research Group (ppAKI). Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol. 2015;16:24. doi:10.1186/s12882-015-0016-6  PMCID:PMC4355130  PMID:25882434  
  24. Dharnidharka VR, Mohanakumar T. New approaches to treating B-cell cancers induced by Epstein-Barr virus. N Engl J Med. 2015;372(6):569-71. doi:10.1056/NEJMcibr1415117  PMID:25651254  
  25. Lentine KL, Yuan H, Tuttle-Newhall JE, Xiao H, Chawa V, Axelrod D, Brennan DC, Dharnidharka VR, Beuer C, Schnitzler MA. Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data. Transplantation. 2015;99(1):187-96. doi:10.1097/TP.0000000000000248  PMID:25531895  
  26. Lentine KL, Lam NN, Xiao H, Tuttle-Newhall JE, Axelrod D, Brennan DC, Dharnidharka VR, Yuan H, Nazzal M, Zheng J, Schnitzler MA. Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol. 2015;41(2):165-76. doi:10.1159/000377685  PMID:25832723  
  27. Foster BJ, Pai A, Zhao H, Furth S, TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrol. 2014;15:139. doi:10.1186/1471-2369-15-139  PMCID:PMC4236658  PMID:25176317  
  28. Smith JM, Dharnidharka VR. Viral surveillance and subclinical viral infection in pediatric kidney transplantation. Pediatr Nephrol. 2014. doi:10.1007/s00467-014-2866-8  PMID:25125226  
  29. Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med. 2014;371(6):549-58. doi:10.1056/NEJMra1314376  PMID:25099579  
  30. Dharnidharka VR, Hesemann LE. The ImmuKnow assay--does it really put us in the know about the immune system? Pediatr Transplant. 2014;18(5):415-6. PMID:25041327  
  31. Lentine KL, Axelrod D, Klein C, Simpkins C, Xiao H, Schnitzler MA, Tuttle-Newhall JE, Dharnidharka VR, Brennan DC, Segev DL. Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation. 2014;98(1):54-65. doi:10.1097/TP.0000000000000029  PMCID:PMC4411309  PMID:24978035  
  32. Al Khasawneh E, Gupta S, Tuli SY, Shahlaee AH, Garrett TJ, Schechtman KB, Dharnidharka VR. Stable pediatric kidney transplant recipients run higher urine indoleamine 2, 3 dioxygenase (IDO) levels than healthy children. Pediatr Transplant. 2014;18(3):254-7. doi:10.1111/petr.12232  PMCID:PMC3981946  PMID:24483723  
  33. Poudel A, Lew J, Slayton W, Dharnidharka VR. Bartonella henselae infection inducing hemophagocytic lymphohistiocytosis in a kidney transplant recipient. Pediatr Transplant. 2014;18(3):E83-7. PMID:24829973  
  34. Anyaegbu EI, Dharnidharka VR. Hypertension in the teenager. Pediatr Clin North Am. 2014;61(1):131-51. doi:10.1016/j.pcl.2013.09.011  PMCID:PMC3947917  PMID:24267462  
  35. Nardone B, Saddleton E, Laumann AE, Edwards BJ, Raisch DW, McKoy JM, Belknap SM, Bull C, Haryani A, Cowper SE, Abu-Alfa AK, Miller FH, Godinez-Puig V, Dharnidharka VR, West DP. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014;44(2):173-80. doi:10.1007/s00247-013-2795-x  PMCID:PMC3946726  PMID:24057195  
  36. Hashim F, Gregg JA, Dharnidharka VR. Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation. Open Urol Nephrol J. 2014;7(Suppl 2 M7):152-157. doi:10.2174/1874303X01407010152  PMID:25821528  
  37. Hashim F, Rehman S, Gregg JA, Dharnidharka VR. Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation. J Transplant. 2014;2014:459747. doi:10.1155/2014/459747  PMCID:PMC4177822  PMID:25295178  
  38. Dharnidharka VR, Kulsum-Mecci N. Non-post-transplant lymphoproliferative disorder cancers in children after organ transplantation. Pediatr Transplant. 2013;17(8):707-9. PMID:24118973  
  39. Dharnidharka VR, Storch GA, Brennan DC. Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med. 2013;369(19):1858-9. doi:10.1056/NEJMc1310006#SA2  PMID:24195556  
  40. Dharnidharka VR, Al Khasawneh E, Gupta S, Shuster JJ, Theriaque DW, Shahlaee AH, Garrett TJ. Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection. Transplantation. 2013;96(6):567-72. doi:10.1097/TP.0b013e31829c7cec  PMCID:PMC3875171  PMID:23823655  
  41. Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, Müller-Wiefel DE, Sander A, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) Registry. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol. 2013;24(4):665-76. doi:10.1681/ASN.2012050433  PMCID:PMC3609132  PMID:23471197  
  42. Moudgil A, Dharnidharka VR, Lamb KE, Meier-Kriesche HU. Best allograft survival from share-35 kidney donors occurs in middle-aged adults and young children-an analysis of OPTN data. Transplantation. 2013;95(2):319-25. doi:10.1097/TP.0b013e3182719203  PMID:23154211  
  43. Lentine KL, Anyaegbu E, Gleisner A, Schnitzler MA, Axelrod D, Brennan DC, Dharnidharka VR, Abraham E, Tuttle-Newhall JE. Understanding medical care of transplant recipients through integrated registry and pharmacy claims data. Am J Nephrol. 2013;38(5):420-9. doi:10.1159/000356092  PMID:24216747  
  44. Glotz D, Chapman JR, Dharnidharka VR, Hanto DW, Castro MC, Hirsch HH, Leblond V, Mehta AK, Moulin B, Pagliuca A, Pascual J, Rickinson AB, Russo FP, Trappe RU, Webster AC, Zuckermann AO, Gross TG. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation. 2012;94(8):784-93. doi:10.1097/TP.0b013e318269e64f  PMID:22992767  
  45. Naesens M, Salvatierra O, Benfield M, Ettenger RB, Dharnidharka V, Harmon W, Mathias R, Sarwal MM, SNS01-NIH-CCTPT Multicenter Trial. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant. 2012;12(10):2730-43. doi:10.1111/j.1600-6143.2012.04144.x  PMCID:PMC3459071  PMID:22694733  
  46. Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, Chen A, Hsieh S, Dai H, Zhang M, Naesens M, Zarkhin V, Sansanwal P, Chen R, Mindrinos M, Xiao W, Benfield M, Ettenger RB, Dharnidharka V, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Davis R, Butte AJ, Salvatierra O, Sarwal MM. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012;12(10):2710-8. doi:10.1111/j.1600-6143.2012.04253.x  PMID:23009139  
  47. Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, Waskerwitz J, Salvatierra O. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant. 2012;12(10):2719-29. doi:10.1111/j.1600-6143.2012.04145.x  PMID:22694755  
  48. Al Khasawneh E, Araya CE, Dharnidharka VR. Missed viral surveillance testing visits associate with full blown viral diseases in children receiving kidney transplants. Pediatr Transplant. 2012. doi:10.1111/j.1399-3046.2012.01773.x  PMID:22905915  
  49. Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Muñoz A. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int. 2012;82(4):445-53. doi:10.1038/ki.2012.169  PMCID:PMC3433576  PMID:22622496  
  50. Dharnidharka VR. Less invasive biomarkers of acute rejection: reaching the elusive clinic. Pediatr Transplant. 2012;16(4):308-9. doi:10.1111/j.1399-3046.2012.01679.x  PMID:22489748  
  51. Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant. 2012;12(4):976-83. doi:10.1111/j.1600-6143.2011.03893.x  PMID:22226225  
  52. Flynn JT, Pierce CB, Miller ER 3rd, Charleston J, Samuels JA, Kupferman J, Furth SL, Warady BA, Chronic Kidney Disease in Children Study Group. Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease. J Pediatr. 2012;160(3):434-440.e1. doi:10.1016/j.jpeds.2011.08.071  PMCID:PMC3274610  PMID:22048052  
  53. Schaefer F, Borzych-Duzalka D, Azocar M, Munarriz RL, Sever L, Aksu N, Barbosa LS, Galan YS, Xu H, Coccia PA, Szabo A, Wong W, Salim R, Vidal E, Pottoore S, Warady BA, IPPN investigators. Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int. 2012;32(4):399-409. doi:10.3747/pdi.2012.00126  PMCID:PMC3524840  PMID:22859840  
  54. Neu AM, Sander A, Borzych-Duzalka D, Watson AR, Vallés PG, Ha IS, Patel H, Askenazi D, Balasz-Chmielewska I, Lauronen J, Groothoff JW, Feber J, Schaefer F, Warady BA, IPPN investigators. Comorbidities in chronic pediatric peritoneal dialysis patients: a report of the International Pediatric Peritoneal Dialysis Network. Perit Dial Int. 2012;32(4):410-8. doi:10.3747/pdi.2012.00124  PMCID:PMC3524853  PMID:22859841  
  55. Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis. 2011;58(6):971-80. doi:10.1053/j.ajkd.2011.07.015  PMID:21930332  
  56. Rees L, Azocar M, Borzych D, Watson AR, Büscher A, Edefonti A, Bilge I, Askenazi D, Leozappa G, Gonzales C, van Hoeck K, Secker D, Zurowska A, Rönnholm K, Bouts AH, Stewart H, Ariceta G, Ranchin B, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) registry. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol. 2011;22(12):2303-12. doi:10.1681/ASN.2010020192  PMCID:PMC3279935  PMID:22021715  
  57. Dodson JL, Jerry-Fluker JV, Ng DK, Moxey-Mims M, Schwartz GJ, Dharnidharka VR, Warady BA, Furth SL. Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rate. J Urol. 2011;186(4):1460-6. doi:10.1016/j.juro.2011.05.059  PMID:21855938  
  58. Dharnidharka VR, Abdulnour HA, Araya CE. The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol. 2011;26(10):1763-74. doi:10.1007/s00467-010-1716-6  PMID:21161285  
  59. Nee R, Hurst FP, Dharnidharka VR, Jindal RM, Agodoa LY, Abbott KC. Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation. Transplantation. 2011;92(2):190-5. doi:10.1097/TP.0b013e3182200e8a  PMID:21577180  
  60. Hurst FP, Jindal RM, Fletcher JJ, Dharnidharka V, Gorman G, Lechner B, Nee R, Agodoa LY, Abbott KC. Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology. 2011;77(6):1271-6. doi:10.1016/j.urology.2011.01.007  PMID:21459420  
  61. Marks WH, Ilsley JN, Dharnidharka VR. Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review. Transplant Proc. 2011;43(5):1395-404. doi:10.1016/j.transproceed.2011.03.036  PMID:21693205  
  62. Dharnidharka VR, Gupta S, Al Khasawneh E, Haafiz A, Shuster JJ, Theriaque DW, Shahlaee AH, Garrett TJ. Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication events. Pediatr Transplant. 2011;15(3):321-8. doi:10.1111/j.1399-3046.2011.01485.x  PMCID:PMC3078420  PMID:21492353  
  63. Dharnidharka VR, Martz KL, Stablein DM, Benfield MR. Improved survival with recent Post-Transplant Lymphoproliferative Disorder (PTLD) in children with kidney transplants. Am J Transplant. 2011;11(4):751-8. doi:10.1111/j.1600-6143.2011.03470.x  PMID:21446977  
  64. Araya CE, Dharnidharka VR. The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant. 2011;2011:374213. doi:10.1155/2011/374213  PMCID:PMC3235904  PMID:22174985  
  65. Abdulnour HA, Araya CE, Dharnidharka VR. Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication. Pediatr Transplant. 2010;14(8):1007-11. doi:10.1111/j.1399-3046.2010.01393.x  PMID:20819180  
  66. Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, Zambrano P, Ahlenstiel T, Bakkaloglu SA, Spizzirri AP, Lopez L, Ozaltin F, Printza N, Hari P, Klaus G, Bak M, Vogel A, Ariceta G, Yap HK, Warady BA, Schaefer F, International Pediatric PD Network (IPPN). The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010;78(12):1295-304. doi:10.1038/ki.2010.316  PMID:20811335  
  67. Gupta S, Fricker FJ, González-Peralta RP, Slayton WB, Schuler PM, Dharnidharka VR. Post-transplant lymphoproliferative disorder in children: recent outcomes and response to dual rituximab/low-dose chemotherapy combination. Pediatr Transplant. 2010;14(7):896-902. doi:10.1111/j.1399-3046.2010.01370.x  PMID:20642490  
  68. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A, American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;10(8):521-6. doi:10.1016/S1473-3099(10)70133-X  PMCID:PMC3045703  PMID:20620116  
  69. Gupta S, Araya CE, Dharnidharka VR. Xanthogranulomatous pyelonephritis in pediatric patients: case report and review of literature. J Pediatr Urol. 2010;6(4):355-8. doi:10.1016/j.jpurol.2009.09.014  PMID:19864185  
  70. Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC. Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant. 2010;10(5):1312-5. doi:10.1111/j.1600-6143.2010.03083.x  PMID:20353461  
  71. Araya CE, Garin EH, Neiberger RE, Dharnidharka VR. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant. 2010;14(1):145-50. doi:10.1111/j.1399-3046.2009.01183.x  PMID:19344337  
  72. Dharnidharka VR, Gupta S. PTLD treatment: reducing the chemotherapy burden through addition of rituximab. Pediatr Transplant. 2010;14(1):10-1. doi:10.1111/j.1399-3046.2009.01289.x  PMID:20078838  
  73. Dharnidharka V, Gupta S. Viral immune monitoring for post-transplant lymphoproliferative disorder. Pediatr Transplant. 2009;13(5):521-3. doi:10.1111/j.1399-3046.2009.01144.x  PMID:19254268  
  74. Dharnidharka VR. Melamine-contaminated powdered formula and urolithiasis. N Engl J Med. 2009;360(25):2676; author reply 2677-8. PMID:19537318  
  75. Araya CE, Mehta MB, González-Peralta RP, Hunger SP, Dharnidharka VR. Native kidney post-transplant lymphoproliferative disorder in a non-renal transplant patient. Pediatr Transplant. 2009;13(4):495-8. doi:10.1111/j.1399-3046.2008.01001.x  PMID:18673359  
  76. Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019-26. doi:10.1097/TP.0b013e31819cc383  PMID:19352121  
  77. Dharnidharka VR, Araya CE. Post-transplant lymphoproliferative disease. Pediatr Nephrol. 2009;24(4):731-6. doi:10.1007/s00467-007-0582-3  PMID:17891420  
  78. Schwartz GJ, Kwong T, Erway B, Warady B, Sokoll L, Hellerstein S, Dharnidharka V, Furth S, Muñoz A. Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol. 2009;24(1):113-9. doi:10.1007/s00467-008-0957-0  PMCID:PMC2788619  PMID:18769945  
  79. Dharnidharka VR, Johnson RJ. Uric acid--a bad acid for the kidney? Pediatr Transplant. 2008;12(8):821-2. doi:10.1111/j.1399-3046.2008.00986.x  PMID:18503480  
  80. Henry DD, Hunger SP, Braylan RC, Dharnidharka VR. Low viral load post-transplant lymphoproliferative disease localized within the tongue. Transpl Infect Dis. 2008;10(6):426-30. doi:10.1111/j.1399-3062.2008.00328.x  PMID:18657087  
  81. Neff RT, Hurst FP, Falta EM, Bohen EM, Lentine KL, Dharnidharka VR, Agodoa LY, Jindal RM, Yuan CM, Abbott KC. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation. 2008;86(10):1474-8. doi:10.1097/TP.0b013e31818b62c8  PMID:19034021  
  82. Bell LE, Bartosh SM, Davis CL, Dobbels F, Al-Uzri A, Lotstein D, Reiss J, Dharnidharka VR. Adolescent Transition to Adult Care in Solid Organ Transplantation: a consensus conference report. Am J Transplant. 2008;8(11):2230-42. doi:10.1111/j.1600-6143.2008.02415.x  PMID:18822088  
  83. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant. 2008;12(7):790-5. doi:10.1111/j.1399-3046.2008.00937.x  PMID:18537898  
  84. Dharnidharka VR, Talley LI, Martz KL, Stablein DM, Fine RN. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS. Pediatr Transplant. 2008;12(6):689-95. doi:10.1111/j.1399-3046.2007.00881.x  PMID:18179637  
  85. Dharnidharka VR, Araya CE, Wadsworth CS, McKinney MC, Howard RJ. Assessing the value of ureteral stent placement in pediatric kidney transplant recipients. Transplantation. 2008;85(7):986-91. doi:10.1097/TP.0b013e318169bf11  PMID:18408579  
  86. Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM. Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant. 2007;7(11):2619-25. doi:10.1111/j.1600-6143.2007.01972.x  PMCID:PMC2778321  PMID:17868060  
  87. Dharnidharka VR, Wesson SK, Fennell RS. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol. 2007;22(9):1395. doi:10.1007/s00467-006-0384-z  PMID:17180360  
  88. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2(5):1037-42. doi:10.2215/CJN.04051206  PMID:17702713  
  89. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR. Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile. Am J Kidney Dis. 2007;50(1):119-23. doi:10.1053/j.ajkd.2007.04.005  PMID:17591531  
  90. Puliyanda DP, Stablein DM, Dharnidharka VR. Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant. 2007;7(3):662-6. doi:10.1111/j.1600-6143.2006.01675.x  PMID:17250558  
  91. Dharnidharka VR, Agodoa LY, Abbott KC. Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data. Am J Transplant. 2007;7(3):653-61. doi:10.1111/j.1600-6143.2006.01674.x  PMID:17250559  
  92. Dharnidharka VR, Agodoa LY, Abbott KC. Effects of urinary tract infection on outcomes after renal transplantation in children. Clin J Am Soc Nephrol. 2007;2(1):100-6. doi:10.2215/CJN.01820506  PMID:17699393  
  93. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1(6):1161-6. doi:10.2215/CJN.01520506  PMID:17699342  
  94. Gould Rothberg BE, Grooms MC, Dharnidharka VR. Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. Obstet Gynecol. 2006;108(3 Pt 2):734-6. doi:10.1097/01.AOG.0000188062.13749.ef  PMID:17018483  
  95. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation. 2006;81(12):1662-7. doi:10.1097/  PMID:16794532  
  96. Araya CE, González-Peralta RP, Skoda-Smith S, Dharnidharka VR. Systemic Epstein-Barr virus infection associated with membranous nephropathy in children. Clin Nephrol. 2006;65(3):160-4. PMID:16550746  
  97. Dharnidharka VR. Infected kidney cysts. Kidney Int. 2006;69(5):783. doi:10.1038/  PMID:16518337  
  98. Araya CE, Clapp WL, Redman RS, Dharnidharka VR. Acute-onset hearing loss with renal failure: differential diagnosis. Am J Kidney Dis. 2006;47(3):553-8. doi:10.1053/j.ajkd.2005.11.028  PMID:16490636  
  99. Araya CE, Lew JF, Fennell RS 3rd, Neiberger RE, Dharnidharka VR. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant. 2006;10(1):32-7. doi:10.1111/j.1399-3046.2005.00391.x  PMID:16499584  
  100. Dharnidharka VR. Post-transplant lymphoproliferative disease: association with induction therapy? Drugs. 2006;66(4):429-38. PMID:16597161  
  101. Abbott KC, Kimmel PL, Dharnidharka V, Oglesby RJ, Agodoa LY, Caillard S. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80(10):1383-91. PMID:16340779  
  102. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233-43. PMID:16314791  
  103. Dharnidharka VR. Costimulation blockade with belatacept in renal transplantation. N Engl J Med. 2005;353(19):2085-6; author reply 2085-6. doi:10.1056/NEJM200511103531919  PMID:16282187  
  104. Dharnidharka VR, Stevens G. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant. 2005;9(5):622-6. doi:10.1111/j.1399-3046.2005.00361.x  PMID:16176420  
  105. Tuli SY, Dharnidharka VR. Utility of renal imaging in the diagnostic evaluation of obese childhood primary hypertension. Clin Pediatr (Phila). 2005;44(7):589-92. PMID:16151564  
  106. Dharnidharka VR. Renal transplantation: the present and the future. Indian J Pediatr. 2005;72(9):785-8. PMID:16186682  
  107. Dharnidharka VR. Sirolimus in pediatric solid organ transplantation. Pediatr Transplant. 2005;9(4):427-9. doi:10.1111/j.1399-3046.2005.00385.x  PMID:16048592  
  108. Dharnidharka VR, Carney PR. Isolated idiopathic hypomagnesemia presenting as aphasia and seizures. Pediatr Neurol. 2005;33(1):61-5. doi:10.1016/j.pediatrneurol.2005.02.005  PMID:15876516  
  109. Dharnidharka VR, Stevens G, Howard RJ. En-bloc kidney transplantation in the United states: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003. Am J Transplant. 2005;5(6):1513-7. doi:10.1111/j.1600-6143.2005.00878.x  PMID:15888062  
  110. Dharnidharka VR, Douglas-Nikitin V. Hodgkin's-like PTLD versus true Hodgkin's disease. Pediatr Transplant. 2004;8(6):581-2. doi:10.1111/j.1399-3046.2004.00225.x  PMID:15598328  
  111. Denton MD, Magee C, Melter M, Dharnidharka VR, Sayegh MH, Briscoe DM. TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. Transplantation. 2004;78(8):1218-21. PMID:15502723  
  112. Jain SM, Wesson S, Hassanein A, Canova E, Hoy M, Fennell RS, Dharnidharka VR. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol. 2004;19(4):467-70. doi:10.1007/s00467-003-1380-1  PMID:14872332  
  113. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant. 2004;4(3):384-9. PMID:14961991  
  114. Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004;8(1):87-90. doi:10.1046/j.1397-3142.2003.00113.x  PMID:15009846  
  115. Dharnidharka V. Dual monoclonal antibody therapy for the treatment of PTLD? Pediatr Transplant. 2003;7(5):337-8. PMID:14738290  
  116. Kwon C, Zaritsky A, Dharnidharka VR. Transient proximal tubular renal injury following Ecstasy ingestion. Pediatr Nephrol. 2003;18(8):820-2. doi:10.1007/s00467-003-1164-7  PMID:12774221  
  117. Dharnidharka VR, Tejani AH, Ho PL, Harmon WE. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant. 2002;2(10):993-8. PMID:12482154  
  118. Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2002;6(5):396-9. PMID:12390426  
  119. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-6. doi:10.1053/ajkd.2002.34487  PMID:12148093  
  120. Naik B, Hirshhorn S, Dharnidharka VR. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis. J Clin Anesth. 2002;14(5):381-4. PMID:12208445  
  121. Dharnidharka VR, Richard GA, Neiberger RE, Fennell RS 3rd. Cat scratch disease and acute rejection after pediatric renal transplantation. Pediatr Transplant. 2002;6(4):327-31. PMID:12234274  
  122. Dharnidharka VR, Fennell RS 3rd, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol. 2002;17(5):312-5. doi:10.1007/s00467-002-0841-2  PMID:12042885  
  123. Dharnidharka VR, Van Patten Y, Bahjat FR, Clare-Salzler M. Fas stimulation results in selective islet infiltrate apoptosis in situ and reversal of diabetes. Ann N Y Acad Sci. 2002;958:160-2. PMID:12021097  
  124. Dharnidharka VR, Harmon WE. Management of pediatric postrenal transplantation infections. Semin Nephrol. 2001;21(5):521-31. PMID:11559893  
  125. Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE, North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;71(8):1065-8. PMID:11374404  
  126. Dharnidharka VR, Ruteshouser EC, Rosen S, Kozakewich H, Harris HW Jr, Herrin JT, Huff V. Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. Pediatr Nephrol. 2001;16(3):227-31. PMID:11322369  
  127. Bahjat FR, Dharnidharka VR, Fukuzuka K, Morel L, Crawford JM, Clare-Salzler MJ, Moldawer LL. Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Immunol. 2000;165(11):6559-67. PMID:11086099  
  128. Dharnidharka VR, Ilyas M, Fennell RS 3rd, Richard GA. Urinary tract infection guidelines questioned. Pediatrics. 2000;105(2):465-6; author reply 466-7. PMID:10691520  
  129. Dharnidharka VR, Schowengerdt K, Skoda-Smith S. Failure of combined costimulatory blockade in animal transplant model. Nat Med. 2000;6(2):115. doi:10.1038/72166  PMID:10655074  
  130. Dharnidharka V. Primary nocturnal enuresis--where do we stand today? Indian Pediatr. 2000;37(2):135-40. PMID:10745407  
  131. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation. 1999;67(12):1626-31. PMID:10401773  
  132. Briscoe DM, Dharnidharka VR, Isaacs C, Downing G, Prosky S, Shaw P, Parenteau NL, Hardin-Young J. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. Transplantation. 1999;67(12):1590-9. PMID:10401767  
  133. Harmon WE, Dharnidharka VR. Lymphoproliferative disease in children. Transplant Proc. 1999;31(1-2):1268-9. PMID:10083565  
  134. Dharnidharka VR, Kandoth P. Paediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area. Indian J Public Health. 1999;43(2):64-6. PMID:11243068  
  135. Dharnidharka VR, Takemoto C, Ewenstein BM, Rosen S, Harris HW. Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B. Pediatr Nephrol. 1998;12(8):654-7. PMID:9811389  
  136. Dharnidharka VR, Rosen S, Somers MJ. Acute interstitial nephritis presenting as presumed minimal change nephrotic syndrome. Pediatr Nephrol. 1998;12(7):576-8. PMID:9761358  
  137. Dharnidharka VR, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 1998;12(6):475-8. PMID:9745872  
  138. Dharnidharka VR, Nadeau K, Cannon CL, Harris HW, Rosen S. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis. 1998;31(4):710-2. PMID:9531191  
  139. Denton MD, Reul RM, Dharnidharka VR, Fang JC, Ganz P, Briscoe DM. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection. Pediatr Transplant. 1998;2(1):6-15. PMID:10084754  
  140. Udani VP, Dharnidharka VR, Gajendragadkar AR, D'Souza B. Extra and central pontine myelinolysis in a child with adrenal insufficiency. Pediatr Neurol. 1997;17(2):158-60. PMID:9367298  
  141. Udani VP, Dharnidharka VR, Gajendragadkar AR. Para/post infectious recovering encephalitis with localized basal ganglia involvement. Indian Pediatr. 1997;34(8):721-6. PMID:9492402  
  142. Udani VP, Dharnidharka VR, Gajendragadkar AR, Udani SV. Sporadic Stiffman syndrome in a young girl. Pediatr Neurol. 1997;17(1):58-60. PMID:9308978  
  143. Dharnidharka VR, Lieh-Lai M, Sarnaik A, Clapp S. A child with cardiogenic shock and supraventricular tachycardia presenting in normal sinus rhythm. Pediatr Emerg Care. 1996;12(6):420-1. PMID:8989789  
  144. Dharnidharka VR, Kandoth PW. Use of banana leaves in Stevens-Johnson syndrome. Pediatr Dermatol. 1994;11(3):280-1. PMID:7971569  
  145. Kandoth PW, Agarwal GJ, Dharnidharka VR. Acute renal failure in children requiring dialysis therapy. Indian Pediatr. 1994;31(3):305-9. PMID:7896366  
  146. Dandge VP, Pagarkar WB, Agarwal M, Dharnidharka VR, Rathi SP. Primary hypokalemic periodic paralysis. Indian Pediatr. 1994;31(3):326-8. PMID:7896370  
  147. Udani VP, Dharnidharka V, Nair A, Oka M. Difficult to control epilepsy in childhood--a long term study of 123 cases. Indian Pediatr. 1993;30(10):1199-206. PMID:8077011  
  148. Dharnidharka VR, Agrawal M, Dandge VP. Albendazole. Indian Pediatr. 1993;30(9):1115-8. PMID:8125597  
  149. Dharnidharka VR, Kandoth PW. Prevalence of bacteriuria in febrile infants. Indian Pediatr. 1993;30(8):987-90. PMID:8125587  
  150. Dharnidharka VR, Kandoth PN, Anand RK. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance. Indian Pediatr. 1993;30(6):745-51. PMID:8132253  
  151. Dharnidharka VR, Bichile SK, Vaidya SS. von Willebrand's disease with gastrointestinal telangiectasia. J Assoc Physicians India. 1993;41(6):395-6. PMID:8005986  
  152. Dandge VP, Dharnidharka VR, Dalwai W, Kandalkar BN, Agrawal M, Phatak AM. Congenital mesangioproliferative nephrotic syndrome associated with cytomegalovirus infection. Indian Pediatr. 1993;30(5):665-7. PMID:8282395  
  153. Dharnidharka VR, Agrawal M, Dandge VP. Acyclovir. Indian Pediatr. 1993;30(4):553-8. PMID:8288352  
  154. Dharnidharka VR. Albendazole--newer therapy for neurocysticercosis. J R Soc Health. 1993;113(1):51. PMID:8437170  
  155. Dharnidharka VR, Bahl NK, Kandoth PW, Kamath JR, Vengsarkar US. Retropharyngeal leiomyoma: case report and review of the literature. Head Neck. 1993;15(2):161-3. PMID:8440616  
  156. Godambe SV, Shah NJ, Dharnidharka VR, Agarwal M, Dalwai WM, Dandge VP. Coin gift: a potentially fatal custom. Indian Pediatr. 1992;29(7):940-1. PMID:1428157  
Wash U School of Medicine
Children's Hospital St. Louis
Children's Discovery Institute
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130